Suchergebnisse - "De Prost, Nicolas"
-
1
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Nat Commun
Nature Communications, Vol 13, Iss 1, Pp 1-1 (2022)Schlagwörter: [SDV] Life Sciences [q-bio], 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, [SDV]Life Sciences [q-bio], Science, Author Correction, 3. Good health
Dateibeschreibung: application/pdf
-
2
Autoren: et al.
Quelle: Critical Care; 6/10/2025, Vol. 29 Issue 1, p1-3, 3p
-
3
Autoren: et al.
Quelle: Annals of Intensive Care ; volume 14, issue 1 ; ISSN 2110-5820
-
4
Autoren: et al.
Quelle: Journal of Intensive Care; 10/30/2025, Vol. 13 Issue 1, p1-15, 15p
-
5
Autoren:
Quelle: ASAIO Journal ; volume 71, issue 10, page e156-e157 ; ISSN 1058-2916 1538-943X
-
6
Autoren:
Quelle: ASAIO Journal ; volume 71, issue 3, page e52-e52 ; ISSN 1058-2916
-
7
Autoren: et al.
Quelle: Intensive Care Medicine Experimental; 11/26/2025, Vol. 13 Issue 1, p1-10, 10p
-
8
Autoren: et al.
Quelle: Annals of Intensive Care; 6/28/2024, Vol. 14 Issue 1, p1-9, 9p
Schlagwörter: THERAPEUTIC use of monoclonal antibodies, CRITICALLY ill, PATIENTS, EXTRACORPOREAL membrane oxygenation, RESEARCH funding, MULTIPLE regression analysis, FISHER exact test, KRUSKAL-Wallis Test, TREATMENT effectiveness, DESCRIPTIVE statistics, CHI-squared test, REVERSE transcriptase polymerase chain reaction, LONGITUDINAL method, ODDS ratio, RESEARCH, INTENSIVE care units, ARTIFICIAL respiration, STATISTICS, ANALYSIS of variance, GENETIC mutation, CONFIDENCE intervals, DATA analysis software, COVID-19, SARS-CoV-2, PHENOTYPES, COVID-19 pandemic, OBESITY, IMMUNOSUPPRESSION
Geografische Kategorien: FRANCE
-
9
Autoren: et al.
Quelle: Critical Care; 6/12/2025, Vol. 29 Issue 1, p1-9, 9p
-
10
Autoren: et al.
Quelle: Critical Care; 5/19/2025, Vol. 29 Issue 1, p1-10, 10p
-
11
Autoren: et al.
Quelle: Annals of Intensive Care; 9/11/2024, Vol. 14 Issue 1, p1-14, 14p
Schlagwörter: ADULT respiratory distress syndrome treatment, PATIENTS, ADULT respiratory distress syndrome, SECONDARY analysis, T-test (Statistics), RESEARCH funding, HOSPITAL admission & discharge, LYING down position, FISHER exact test, TREATMENT duration, TREATMENT effectiveness, DESCRIPTIVE statistics, MANN Whitney U Test, CHI-squared test, LONGITUDINAL method, KAPLAN-Meier estimator, INTENSIVE care units, ARTIFICIAL respiration, RESEARCH, SURVIVAL analysis (Biometry), BODY movement, COVID-19, CRITICAL care medicine, PROPORTIONAL hazards models
Geografische Kategorien: FRANCE, SWITZERLAND, BELGIUM
-
12
Autoren: et al.
Quelle: Critical Care; 4/20/2024, Vol. 28 Issue 1, p1-11, 11p
-
13
Autoren: et al.
Quelle: Critical Care; 4/30/2023, Vol. 27 Issue 1, p1-6, 6p
-
14
Autoren: et al.
Quelle: PLoS ONE; 4/18/2024, Vol. 19 Issue 4, p1-11, 11p
Schlagwörter: SICKLE cell anemia, CEFOTAXIME, ACUTE diseases, LENGTH of stay in hospitals, TEACHING hospitals
-
15
Autoren: et al.
Quelle: Critical Care; 10/10/2025, Vol. 29 Issue 1, p1-12, 12p
-
16
Autoren: et al.
Quelle: Intensive Care Medicine; Mar2024, Vol. 50 Issue 3, p385-394, 10p
-
17
Autoren: et al.
Quelle: Annals of Intensive Care; 1/11/2022, Vol. 12 Issue 1, p1-2, 2p
-
18
Autoren: et al.
Quelle: Intensive Care Medicine; Oct2019, Vol. 45 Issue 10, p1487-1489, 3p, 1 Diagram
-
19
Autoren: et al.
Quelle: Intensive Care Medicine; May2023, Vol. 49 Issue 5, p611-611, 1p
Schlagwörter: INTENSIVE care patients, SYMPTOMS, EPIDEMIOLOGY
-
20
Autoren: et al.
Quelle: PLoS ONE; 2/12/2025, Vol. 20 Issue 2, p1-1, 1p
Schlagwörter: SICKLE cell anemia, ACUTE diseases, CEFOTAXIME, SYNDROMES
Full Text Finder
Nájsť tento článok vo Web of Science